Literature DB >> 18038498

Plasma skin regeneration technology.

Melissa A Bogle1, Kenneth A Arndt, Jeffrey S Dover.   

Abstract

Plasma skin regeneration is a novel type of skin rejuvenation technology developed over the last 3 years. Plasma is the fourth state of matter in which electrons are stripped from atoms to form an ionized gas. Although high temperature plasmas have been used in surgery for over a decade, plasma had previously been used as a conduction medium for electric current. Unlike lasers which rely on the principle of selective photothermolysis to deliver heat to specific targets in the skin, plasma technology delivers heat energy directly to tissue upon contact without reliance on skin chromophores. The plasma itself produces controlled thermal damage to the skin surface to elicit changes such as new collagen formation and improvement in photodamaged skin. The technology can be used at varying energies for different depths of effect, from superficial epidermal effects to deeper dermal heating.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18038498

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  3 in total

1.  Plasma discharge and time-dependence of its effect to bacteria.

Authors:  I Justan; L Cernohorska; Z Dvorak; P Slavicek
Journal:  Folia Microbiol (Praha)       Date:  2014-01-25       Impact factor: 2.099

2.  A novel fractional micro-plasma radio-frequency technology for the treatment of facial scars and rhytids: a pilot study.

Authors:  Shlomit Halachmi; Arie Orenstein; Tania Meneghel; Moshe Lapidoth
Journal:  J Cosmet Laser Ther       Date:  2010-10       Impact factor: 2.247

Review 3.  Cold Atmospheric Pressure Plasma (CAP) as a New Tool for the Management of Vulva Cancer and Vulvar Premalignant Lesions in Gynaecological Oncology.

Authors:  Pavol Zubor; Yun Wang; Alena Liskova; Marek Samec; Lenka Koklesova; Zuzana Dankova; Anne Dørum; Karol Kajo; Dana Dvorska; Vincent Lucansky; Bibiana Malicherova; Ivana Kasubova; Jan Bujnak; Milos Mlyncek; Carlos Alberto Dussan; Peter Kubatka; Dietrich Büsselberg; Olga Golubnitschaja
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.